Chromium and exercise training: Effect on obese women

Medicine and Science in Sports and Exercise

Volumn 29, Issue 8, 1997, Pages 992-998

  Grant, Kristen E ^a   Chandler, Resa M ^a   Castle, Arthur L ^a   Ivy, John L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Body composition; Body weight; Chromium supplementation; Glucose; Insulin; Lipids

Indexed keywords

CHROMIUM NICOTINATE; CHROMIUM PICOLINATE; GLUCOSE; INSULIN; NICOTINIC ACID DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXERCISE; FEMALE; HUMAN; INSULIN RESPONSE; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; FEMALE; FOOD, FORTIFIED; HUMANS; INSULIN; IRON CHELATING AGENTS; NICOTINIC ACIDS; OBESITY; PICOLINIC ACIDS; RISK FACTORS; WEIGHT GAIN; WEIGHT LOSS;

EID: 0030739694     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199708000-00003     Document Type: Article

References (37)

1. ABRAHAM, A. S., B. A. BROOKS, and U. EYLATH. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41: 768-771, 1992,
2. ANDERSON, R. A., M. M. POLANSKY, N. A. BRYDER, and J. J. CANARY. Supplemental-chromium effects on glucose, insulin, glucagon and urinary chromium losses in subjects consuming controlled low-chromium diets. Am. J. Clin. Nutr. 54:909-916, 1991.
3. BEHNKE, A. R. and J. H. WILMORE. Evaluation and Regulation ofBody Build and Composition. Englewood Cliffs, NJ: Prentice-Hall, 1974, pp.
4. BLACKBURN, G., and B. KANDERS (Eds.). Obesity Pathophysiology,Psychology, and Treatment. Chapman Hall Series in ClinicalNutrition, New York: Chapman and Hall, 1994, pp.
5. CASTELLI, W. P., R. J. GARRISON, P. W. F. WILSON, R. D. ABBOTI, S.KALOUSDIAN, and W. B. KANNEL. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 256:2835-2838, 1986.
6. CLANCY, S. P., P. M. CLARKSON, M. E. DECHEKE, et al. Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players. Int. J. Sport Nutr. 4:142-153, 1994.
7. DAVIDSON, J. K. Clinical Diabetes Mellitus. New York: Thieme Medical Publishers, Inc., 1991, pp.
8. DIORDJEVIC, P. B., V. DIMITRIJEVIC, R. MAKSIMOVIC, M. VIVIC, andJ. VUCETIC. Application of organic bound chrome in disturbed glycoregulation therapy. Transplant. Proc. 27:3333-3334, 1995.
9. DONALDSON, D. L., P. LEE, C. C. SMITH, and O. M. RENNELL.Glucose tolerance and plasma lipid distribution in rats fed a high sucrose, high cholesterol, low Cr diet. Metabolism 34:1086-1093,1985.
10. DURSTINE, J. L. and W. L. HASKELI. Effects of exercise training onplasma lipids and lipoproteins. In: Exercise and Sport Sciences Reviews. Vol. 22, J. O. Holloszy (Ed.). Baltimore: Williams andWilkins, 1994, pp.
11. EVANS, G. W. The effect of chromium picolinate on insulin controlled parameters in humans. Int. J. Biosoc. Med. Res. 11:163-180, 1989.
12. EVANS, G. W. and D. J. POUCHNIK. Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49:177-187, 1993.
13. GLINSMANN, W. H. and W. MERTZ. Effect of trivalent chromium on glucose tolerance. Metabolism 15:510-515, 1966.
14. HALLMARK, M. A., T. H. REYNOLDS, C. A. DESOUZA, C. D. DOTSON, R. A. ANDERSON, and M. A. ROGERS. Effects of chromium and resistive training on muscle strength and body composition. Med. Sci. Sports Exerc. 28:139-144, 1996.
15. HASKELL, W. L. The influence of exercise training on plasma lipids and lipoproteins in health and disease. Acta Med. Scand. (Suppl.) 711:25-37, 1986.
16. HASTEN, D. L., E. P. ROME, B. D. FRANKS, and M. HAYSTED. Effect of chromium picolinate on beginning weight training students. Int. J. Sports Nutr. 2:343-350, 1992.
17. HEATH, G. W., J. R. GAVIN III, J. M. HINDERLITER, J. M. HAGBERG, S. A. BLOOMFIELD, and J. O. HOLLOSZY. Effects of exercise and lack of exercise on glucose tolerance and insulin action. J. Appl. Physiol. 55:512-517, 1983.
18. JEEJEEHBOY, K. N., R. C. CHU, E. B. MARLISS, R. GRUN, and A. S.BRUCE-ROBERTSON. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term parenteral nutrition. Am. J. Clin. Nutr. 30: 531-538, 1977.
19. KAATS, G. R., J. A. FISHER, and K. BLUM. The effects of chromium picolinate supplementation on body composition in different age groups (Abstract). Presented at American Aging Association 21st Annual Meeting, Denver, CO. October, 1991.
20. KANNEL, W. B. and D. L. MCGEE. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8-13, 1979.
21. LEE, N. A. and C. A. REASNER. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17:1449-1452, 1994.
22. LEVINE, R. A., D. H. STREETEN, and R. J. DOISY. Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects. Metabolism 17:114-125, 1968.
23. MIKINES, K. J., B. SONNE, P. A. FARRELL, B. TRONIER, and H.GABLO. Effect of training on the dose-response relationship for insulin action in men. J. Appl. Physiol. 66:695-703, 1989.
24. OFFENBACHER, E. G. and F. X. PI-SUNYER. Chromium in human nutrition. Ann. Rev. Nutr: 8:543-563, 1988.
25. PAGE, T. G., T. L. WARD, and L. L. SOUTHERN. Effect of chromium picolinate on growth and carcass characteristics of growing-finishing pigs. J. Am. Sci. 69:(Suppl.1):403, 1991.
26. POLLOCK, M. and D. SCHMIDT (Eds.). Heart Disease and Rehabil-itation, 3rd Ed. New York: John Wiley and Sons, Inc., 1995, pp.
27. PRESS, R. L. J. GELLER, and G. W. EVANS. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J. Med. 152:41-45, 1990.
28. RIALES, R. Chromium in Nutrition and Metabolism. New York: Elsevier/North-Holland Biomedical Press, 1979.
29. ROEBACK, J. R., K. M. HLA, L. E. CHAMBLESS, and R. H. FLETCHER.Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta blockers. Ann. Int. Med. 115:917-924, 1991.
30. SCHWARTZ, K. and W. MERTZ. Chromium (III), the glucose toler-ance factor. Arch. Biochem. Biophys. 85:292-295, 1959.
31. SHARMA, A. M. Effects of nonpharmacological intervention on insulin sensitivity. J. Cardiovasc. Pharmacol. 20(Suppl 11): S27-34, 1992.
32. STEFANICK, M. L. Exercise and weight control. In: Exercise and Sport Sciences Reviews, Vol. 21, J. O. Holloszy (Ed.). Baltimore: Williams & Wilkins, 1993, pp.
33. UUSITUPA, M. L. L. MYKKANEN, O. SITONEN, et al. Chromium supplementation in impaired glucose tolerance of the elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br. J. Nutr. 68:209-216, 1992.
34. WALLBERG-HENRIKSSON, H. Exercise and diabetes mellitus. In: Exercise and Sport Science Reviews, Vol. 20, J. O. Holloszy, (Ed.). Baltimore: Williams & Wilkins, 1992, pp.
35. WEST, K. M. Epidemiology of Diabetes and its Vascular Lesions. New York: Elsevier, 1978, pp.
36. WILSON, B. E. and A. GONDY. Effects of chromium supplementation on fasting insulin and lipid parameters in healthy, non-over-weight young subjects. Diabetes Res. Clin. Prac. 28: 179-184, 1995.
37. YASPELKIS, B. B., J. G. PATTERSON, P. A. ANDERLA, Z. DING, and J. L. IVY. Carbohydrate supplementation spares muscle glycogen during variable intensity exercise. J. Appl. Physiol. 75:1477-1485, 1993.